Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prognostic Investigations of B7-H1 and B7-H4 Expression Levels As Independent Predictor Markers of Renal Cell Carcinoma Publisher



Safaei HR1 ; Rostamzadeh A2 ; Rahmani O3 ; Mohammadi M4 ; Ghaderi O5 ; Yahaghi H6 ; Ahmadi K7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pediatric Nephrology, AJA University of Medical Sciences, Tehran, Iran
  2. 2. Department of Anatomical Sciences, Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran
  3. 3. Department of Pathology, Be’sat Hospital, AJA University of Medical Sciences, Tehran, Iran
  4. 4. Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran
  5. 5. Department of Pharmaceutical Biotechnology, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Molecular Biology, Baqiyatallah University of Medical Sciences, Tehran, Iran
  7. 7. Department of Emergency Medicine, Alborz University of Medical Sciences, Karaj, Iran

Source: Tumor Biology Published:2016


Abstract

In order to evaluate the correlation of B7-H4 and B7-H1 with renal cell carcinoma (RCC), we analyzed B7-H1 and B7-H4 expressions and their clinical significance by immunohistochemical method. Our result indicated that B7-H4-positive staining was detected in 58.13 % of RCC tissues (25 tissues tumors), and there were 18 tissues of patients without detectable B7-H4. Furthermore, 21 cases (48.83 %) were B7-H1-positive. Positive tumor expressions of B7-H4 and B7-H1 were markedly related to advanced TNM stage (P = 0.001; P = 0.014), high grade (P = 0.001; P = 002), and larger tumor size (P = 0.002; P = 024) in RCC tissues than patients with B7-H4-negative and B7-H1-negative in RCC tissues. The patients with B7-H1 and B7-H4-positive expressions were found to be markedly correlated with the overall survival of the patients (P < 0.05) and tended to have an increased risk of death when compared with negative expression groups. Univariate analysis showed that B7-H4 and B7-H1 expressions, TNM stage, high grade, and tumor size were significantly related to the prognosis of RCC. Furthermore, multivariate analysis showed that B7-H4 and B7-H1 expressions decreased overall survival. The adjusted HR for B7-H1 was 2.83 (95 % CI 1.210–2.971; P = 0.031) and also was 2.918 (95 % CI 1.243–3.102; P = 0.006) for B7-H4 that showed these markers were independent prognostic factors in RCC patients. The expressions of B7-H1 and B7-H4 in RCC patients indicate that these markers may be as a predictor of tumor development and death risk. Further investigations can be helpful to confirm B7-H1 and B7-H4 roles as an independent predictor of clinical RCC outcome. © 2015, International Society of Oncology and BioMarkers (ISOBM).
Related Docs
1. Pd-1 and Cancer: Molecular Mechanisms and Polymorphisms, Immunogenetics (2018)
2. Targeting the Pd-1/Pd-L1 Pathway in Glioblastoma Multiforme: Preclinical Evidence and Clinical Interventions, International Immunopharmacology (2021)
3. Immunotherapy of Cancers Comes of Age, Expert Review of Clinical Immunology (2017)
4. Immune Checkpoint Inhibitor (Ici) Therapy in Central Nervous System Cancers: State-Of-The-Art and Future Outlook, International Immunopharmacology (2025)
5. Exhaustion of T Lymphocytes in the Tumor Microenvironment: Significance and Effective Mechanisms, Cellular Immunology (2017)
6. Upregulation of Galectin-9 and Pd-L1 Immune Checkpoints Molecules in Patients With Chronic Lymphocytic Leukemia, Asian Pacific Journal of Cancer Prevention (2017)
7. Clinical Relevance and Prognostic Significance of Pd-1/Pd-Ls in Non-Metastatic Bladder Cancer: A Role for Pd-L2, Molecular Immunology (2020)
8. Review of the Recent Clinical Trials for Pd-1/Pd-L1 Based Lung Cancer Immunotherapy, Expert Review of Anticancer Therapy (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (3)
Ghasem Janbabaei (1)